{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Northbrook",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "69246",
      "recalling_firm": "Astellas Pharma US Inc",
      "address_1": "1 Astellas Way",
      "address_2": "",
      "postal_code": "60062-6111",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0008-2015",
      "product_description": "Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle,  Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01",
      "product_quantity": "9,236 bottles",
      "reason_for_recall": "Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.",
      "recall_initiation_date": "20140915",
      "center_classification_date": "20141007",
      "termination_date": "20150519",
      "report_date": "20141015",
      "code_info": "Lot 66482CW, Exp 04/16",
      "more_code_info": ""
    }
  ]
}